Rubella Eradication: Not Yet Accomplished, but Entirely Feasible

• Abstract
• Supplementary data

Preventing Infection by Human Cytomegalovirus

• Abstract

Review of Mathematical Models of Vaccination for Preventing Congenital Cytomegalovirus Infection

• Abstract

The Status of Vaccine Development Against the Human Cytomegalovirus

• Abstract

Is There a Correlate of Protection for Measles Vaccine?

• Extract

Seroconversion for Cytomegalovirus Infection During Pregnancy and Fetal Infection in a Highly Seropositive Population: “The BraCHS Study,” by Mussi-Pinhata et al

• Extract

Increasing Complexity of Vaccine Development

• Abstract

Possible Options for New Pertussis Vaccines Get access

• Abstract

Congenital Transmission of HHV-6 Get access

• Extract

Varicella Vaccination in Japan, South Korea, and Europe Get access

• Abstract

Meningococcal Control in the United States and Africa Get access

• Extract

Vaccines, Vaccination, and Vaccinology Get access

• Extract

A Canarypox Vector Expressing Cytomegalovirus (CMV) Glycoprotein B Primes for Antibody Responses to a Live Attenuated CMV Vaccine (Towne) Get access

• Abstract

Cost of Varicella in France: A Study in Day Care Centers Get access

• Abstract

Antibody Persistence Following Preexposure Regimens of Cell-Culture Rabies Vaccines: 10-Year Follow-Up and Proposal for a New Booster Policy Get access

• Abstract

Sequential and Combined Use of Inactivated and Oral Poliovirus Vaccines: Dolj District, Romania, 1992–1994 Get access

• Abstract

Mucosal Antibodies to Human Cytomegalovirus Glycoprotein B Occur following both Natural Infection and Immunization with Human Cytomegalovirus Vaccines Get access

• Abstract

Rubella Vaccine Get access

Immunity Induced By Primary Human Cytomegalovirus Infection Protects Against Secondary Infection Among Women Of Childbearing Age Get access

• Abstract

Vaccination in the 21st Century Get access

• Abstract